American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd edn. Arlington, VA: American Psychiatric Association, 2010. Available from https://www.guidelinecentral.com/summaries/practice-guideline-for-the-treatment-of-patients-with-major-depressive-disorder-third-edition/Google Scholar

Bangs, ME, Jin, L, Desaiah, D, et al. Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. Drug Saf 2012: 31:345–54. https://doi.org/10.2165/00002018-200831040-00008Google Scholar

Birmaher, B, Brent, D, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:1503–26. https://doi.org/10.1097/chi.0b013e318145ae1cCrossRefGoogle ScholarPubMed

Blankenstein, MA. Reference intervals – ever met a normal person? Ann Clin Biochem 2015; 52:5–6. https://doi.org/10.1177/0004563214561563CrossRefGoogle Scholar

Carandang, C, Jabbal, R, Macbride, A, Elbe, D. A review of escitalopram and citalopram in child and adolescent depression. J Can Acad Child Adolesc Psychiatry 2011; 20:315–24.Google Scholar

Dulcan, MK, Benson, RS. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 1997; 36:1311–17. https://doi.org/10.1097/00004583-199709000-00033CrossRefGoogle ScholarPubMed

Dynamed. Abnormal liver function tests – approach to the patient. 2018. Available from: https://www.dynamed.com/topics/dmp~AN~T316452 (accessed March 26, 2021).Google Scholar

Eli Lilly and Company. Medication Guide: Strattera. Indianapolis, IN: Eli Lilly and Company, 2003. Available from: http://pi.lilly.com/us/strattera-ppi.pdfGoogle Scholar

Felitti, VJ, Anda, RF, Nordenberg, D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998; 14:245–58. https://doi.org/10.1016/s0749-3797(98)00017-8CrossRefGoogle ScholarPubMed

Fugh-Berman, A. Herbal medicinals: selected clinical considerations, focusing on known or potential drug–herb interactions. Arch Intern Medi 1999; 159:1957–9. https://doi.org/10.1001/archinte.159.16.1957Google Scholar

Garland, EJ, Kutcher, S, Virani, A, Elbe, D. Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice. J Can Acad Child Adolesc Psychiatry 2016; 25:4–10.Google Scholar

Hagerman, RJ, Berry-Kravis, E, Hazlett, HC, et al. Fragile X syndrome. Nat Rev Dis Primers, 2017; 3, 17065. https://doi.org/10.1038/nrdp.2017.65CrossRefGoogle ScholarPubMed

Kratochvil, CJ, Newcorn, JH, Arnold, LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry, 2005; 44: 915–24. https://doi.org/10.1097/01.chi.0000169012.81536.38CrossRefGoogle ScholarPubMed

March, JS. The Treatment for Adolescents with Depression Study (TADS). Washington, DC: American Academy for Child and Adolescent Psychiatry, 2006. Available from: https://www.aacap.org/aacap/families_and_youth/Resources/Psychiatric_Medication/The_Treatment_for_Adolescents_with_Depression_Study_TADS.aspx (accessed March 26, 2021).Google Scholar

March, J, Silva, S, Vitiello, B. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 2006; 45:1393–403. https://doi.org/10.1097/01.chi.0000237709.35637.c0CrossRefGoogle ScholarPubMed

Muhle, RA, Reed, HE, Vo, LC, et al. (2017). Clinical diagnostic testing for individuals with developmental disorders. J Am Acad of Child Adolesc Psychiatry 56:910–13. https://doi.org/10.1016/j.jaac.2017.09.418CrossRefGoogle ScholarPubMed

National Institute of Diabetes and Digestive and Kidney Diseases. Atomoxetine. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548671/Google Scholar

Roberts, EA, Schilsky, ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089–111. https://doi.org/10.1002/hep.22261Google Scholar

Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905–17. https://doi.org/10.1176/ajp.2006.163.11.1905Google Scholar

Siegel, M, McGuire, K, Veenstra-VanderWeele, J, et al. Practice parameter for the assessment and treatment of psychiatric disorders in children and adolescents with intellectual disability (intellectual developmental disorder). J Am Acad Child Adolesc Psychiatry 2019; 59:468–96. https://doi.org/10.1016/j.jaac.2019.11.018Google ScholarPubMed

Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017.Google Scholar

Varigonda, AL, Jakubovski, E, Taylor, MJ, et al. Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder. J Am Acad of Child Adolesc Psychiatry 2015; 54:557–64. https://doi.org/10.1016/j.jaac.2015.05.004Google Scholar

Whyte, MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010; 1192: 190–200. https://doi.org/10.1111/j.1749-6632.2010.05387.xCrossRefGoogle ScholarPubMed